®copyright rubinfeld 2013 cxlusa clinical trial results s. lance forstot, md, facs corneal...
TRANSCRIPT
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CXLUSA Clinical Trial Results
S. Lance Forstot, MD, FACSCorneal Consultants of Colorado
Founding Partner
Clinical Professor of Ophthalmology
University of Colorado
School of Medicine
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CXLUSA Clinical Trial Results
Roy S. Rubinfeld, MA, MD Georgetown University Medical Center,
Washington Hospital Center, Washington, DC
Dr. Rubinfeld has intellectual property Dr. Rubinfeld has intellectual property in corneal strengthening technology and in corneal strengthening technology and
financial interests in CXLO and CXLUSA financial interests in CXLO and CXLUSA
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
o Non-commercial, physician-sponsored UV research studies approved by IRBs since
2009. No IP, no investors Limited number of centers
o Commercial start up with IP, investors, BOD, Novel Technology, Commercial Drug, Advisors
What’s What?
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CXLUSA Study Group Centers
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CXLUSA Study Group Centers
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CXLUSA Study Group Centers
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CXLUSA Study Group Centers
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CXL Mythology
Epi-Off is Better Epi-On is Better
Epithelium removal is needed to load the stroma
with riboflavin
See pictures
Transepithelial Riboflavin Loading @12 min
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
15 Min Epi-On CXLO (~20 y/o pt)Cobalt Blue Light SL Pix
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Epi-on Flare
Epi-Off is Better Epi-On is Better
With Epi-On CXL, the riboflavin only loads epithelium
which blocks the UVA and limits CXL
See picture
15 Min Epi-On CXLO White Light SL Pix (18 y/o Pt)
Epi-Off is Better Epi-On is Better
Epithelium off CXL is safer than epi-on
See pictures
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Haze after Epi-Off CXL
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Delayed Epithelial Healing and Infiltrate after Epi-Off CXL
Postop Day 2Postop Day 2
Courtesy of W. Trattler, MD Courtesy of W. Trattler, MD
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013Postop Day 5Postop Day 5
Perforation after Epi-Off CXL
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Epi-off Complications
o Microbial keratitis after corneal collagen crosslinking. Perez-Santonja JCRS 2009;35(6):1138-40o Pseudomonas keratitis after collagen crosslinking for
keratoconus: case report and review of literature. Sharma. JCRS 2010;36(3):517-20o Complication and failure rates after corneal crosslinking.
Koller, Seiler, et. al. JCRS 2010;36(1):185o Permanent corneal haze after riboflavin-UVA-induced
cross-linking in keratoconus. Raiskup, Spoerl, JRS2009 Sep;25(9):S824-8.
o Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome. Ophthalmologe. 2010 Oct; 107(10):951-5
o Corneal melting corneal collagen cross-linking for keratoconus: A case report. Labiris. Journal of Medical Case Reports 5:15 2012
o Early ocular surface-related complications after CXL. Gutman. Modern Medicine Sept, 2012.
Critical Balance of 3 Reactants is Essential
Riboflavin
UV light Oxygen
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Clear Cornea- Epi-On CXL POD 1
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Safety Treat thinner, steeper, younger corneas, Return to preop vision, function POD 1 Return to CLs in days 1 day of discomfort KCN as indication for PKP
Epi-On Advantages
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Epi-on is not “better” if it doesn’t work
But
Clinical Experience - Keratoconus
c/o William Trattler, MD
Vision Improvement (>= 1 line of vision) CXLUSA vs. Hersh/Avedro
N = 177 N = 48 N = 49 N = 48N = 177 N = 49
1 Year Results (Advanced KCN)
Formulation 1 (36 eyes)
UCVA:Improved ≥1 Lines: 56%Worsened: 3%
No Change: 40%BSCVA:
Improved 1 ≥ Lines: 41%Worsened: 32%No Change: 24%
K Max: Avg Flattening vs. Pre Op=
1.55D
Formulation 2
(31 eyes)UCVA:
Improved ≥1 Lines: 64%Worsened: 8%No Change: 28%
BSCVA:Improved 1≥ Lines: 56%Worsened: 8%No Change: 35%
K Max:Avg Flattening vs. Pre Op=
1.41D
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Epi- On CXLUSA Results
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Stops ProgressionMild improvement in ~50% Can we do better
for advanced cases?
Limitations of CXL Alone
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Terrific for early KCN before vision is lost CXL stops progression of vision loss and
corneal steepening For those who have lost vision from KCN
or ectasia, CXL usually yields only mild improvement in vision and topo/tomos
Can we do better for more adv cases?
Limitations of CXL Alone
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
What if we Could Do This Consistently With Two Non-invasive Procedures?
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
No Finger Pressure
Finger Pressure at
6 o’clock20/200 20/40
Finger Pressure at
7 o’clock20/30+
Observant keratoconus patients sometimes point out, “Pressing on my eye right here, my vision gets
much sharper.”
c/o Anita Nevyas Wallace, MD
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
CK Plus CXL Technique
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Immediately Postop CK vs Preop
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
27 y/o F Caucasian w KCN @ 1 MoVAsc PREOP: 20/80 VAsc 1 MO PO: 20/20- Preop RFx:
-2.00 +5.50 X 170 20/25
1 MO PO RFx: pl +0.75 X 150 20/25+
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
27 y/o F Caucasian w KCN @ 6 Mo
VAsc PREOP : 20/80 VAsc 6 MO PO : 20/25- Preop RFx: -2.00+5.50 X 170 20/25 6 MO PO RFx: pl + 1.25 X 155 20/25
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Ongoing Data Collection
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
There are known knowns; there are things we know that we know. There are
known unknowns; that is to say there are things that,
we now know we don't know. But there are also
unknown unknowns – there are things we do not know, we don't know. 2/12/02
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
“Known Known”
Epi-On is safer, as effective and likely to supplant Epi-Off
Known unknown: Epi-On CXL may
“lock in” CK and become important procedure
®Copyright Rubinfeld 2013Copyright Rubinfeld 2013
Thank You